ZA93453B - Antibiotic compounds - Google Patents

Antibiotic compounds

Info

Publication number
ZA93453B
ZA93453B ZA93453A ZA93453A ZA93453B ZA 93453 B ZA93453 B ZA 93453B ZA 93453 A ZA93453 A ZA 93453A ZA 93453 A ZA93453 A ZA 93453A ZA 93453 B ZA93453 B ZA 93453B
Authority
ZA
South Africa
Prior art keywords
antibiotic compounds
antibiotic
compounds
Prior art date
Application number
ZA93453A
Other languages
English (en)
Inventor
Michael John Betts
Gareth Morse Davies
Michael Lingard Swain
Original Assignee
Zeneca Ltd
Zeneca Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd, Zeneca Pharma Sa filed Critical Zeneca Ltd
Publication of ZA93453B publication Critical patent/ZA93453B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA93453A 1992-02-04 1993-01-21 Antibiotic compounds ZA93453B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds

Publications (1)

Publication Number Publication Date
ZA93453B true ZA93453B (en) 1993-08-05

Family

ID=10709764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93453A ZA93453B (en) 1992-02-04 1993-01-21 Antibiotic compounds

Country Status (35)

Country Link
US (7) US5478820A (zh)
EP (1) EP0579826B1 (zh)
JP (1) JP2730600B2 (zh)
KR (1) KR100200986B1 (zh)
CN (1) CN1036006C (zh)
AP (1) AP398A (zh)
AT (1) ATE173262T1 (zh)
AU (1) AU668133B2 (zh)
CA (1) CA2106370C (zh)
CZ (1) CZ286878B6 (zh)
DE (2) DE69322007T2 (zh)
DK (1) DK0579826T3 (zh)
ES (1) ES2123654T3 (zh)
FI (1) FI104074B (zh)
GB (2) GB9202298D0 (zh)
GE (1) GEP20022694B (zh)
HK (1) HK1013998A1 (zh)
HR (1) HRP930103B1 (zh)
HU (3) HU213675B (zh)
IL (1) IL104588A (zh)
LU (1) LU90970I2 (zh)
MY (1) MY111685A (zh)
NL (1) NL300104I2 (zh)
NO (2) NO304315B1 (zh)
NZ (2) NZ272038A (zh)
PL (3) PL174649B1 (zh)
RU (1) RU2117659C1 (zh)
SG (1) SG48817A1 (zh)
SI (1) SI9300056B (zh)
SK (1) SK280890B6 (zh)
TW (1) TW408124B (zh)
UA (1) UA44885C2 (zh)
WO (1) WO1993015078A1 (zh)
YU (1) YU48998B (zh)
ZA (1) ZA93453B (zh)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
GB9515975D0 (en) * 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
AR008255A1 (es) * 1996-07-12 1999-12-29 Merck & Co Inc Procedimiento para sintetizar antibioticos de carbapenem
EP0923545A1 (en) 1996-08-17 1999-06-23 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
ES2187825T3 (es) * 1996-10-10 2003-06-16 Merck & Co Inc Procedimiento para sintetizar intermedios de la cadena lateral de carbapenem.
US5877328A (en) * 1996-10-10 1999-03-02 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
EP0937079A4 (en) * 1996-10-28 2001-01-24 Merck & Co Inc CARBAPENEM-STABILIZED ANTIBIOTIC COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
JP3245427B2 (ja) * 1997-06-16 2002-01-15 メルク エンド カンパニー インコーポレーテッド 安定化されたカルバペネム中間体および合成における使用
CA2294341C (en) * 1997-07-10 2007-09-25 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
JP3953274B2 (ja) * 1998-03-02 2007-08-08 メルク エンド カムパニー インコーポレーテッド カルバペネム抗生物質の合成方法
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
US6489471B1 (en) 1998-06-17 2002-12-03 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates, and compounds produced
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
US6486150B2 (en) 1999-10-29 2002-11-26 Merck & Co., Inc. Process for formulation of antibiotic compounds
GB9930318D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
WO2003026572A2 (en) * 2001-09-26 2003-04-03 Merck & Co., Inc. Crystalline forms of ertapenem sodium
PL218808B1 (pl) 2001-09-26 2015-01-30 Merck & Co Inc Sposób zmniejszania poziomów rozpuszczalników organicznych w stałym karbapenemie
AU2002366444A1 (en) * 2001-11-08 2003-09-09 Merck & Co., Inc. Compounds useful in the treatment of anthrax
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
AU2003239599B8 (en) * 2002-05-29 2008-08-14 Merck Sharp & Dohme Corp. Compounds useful in the treatment of anthrax and inhibiting lethal factor
WO2005111986A2 (en) * 2004-05-07 2005-11-24 Infinium Labs, Inc. Multi-position multi-level user interface system
CA2566191A1 (en) * 2004-05-11 2005-12-15 Merck & Co., Inc. Process for making n-sulfonated-amino acid derivatives
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)－1－(4－硝基苄氧羰基)－2－[(3－烯丙氧羰基)－苯基氨基甲酰基]－吡咯烷－4－基硫醇的制备方法
PL1965798T3 (pl) 2005-12-07 2012-02-29 Basilea Pharmaceutica Ag Użyteczne antybiotyki monobaktamowe
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
US8293894B2 (en) * 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN101357916B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有二氢咪唑甲酰胺基的培南化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
CN101362761B (zh) * 2007-08-12 2011-05-18 山东轩竹医药科技有限公司 含有巯基哌啶的碳代青霉烯抗生素
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
CN101376641B (zh) * 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
US20110172201A1 (en) * 2008-06-11 2011-07-14 Ranbaxy Laboratories Limited Process for preparing a carbapenem antibiotic composition
AU2009277936B2 (en) * 2008-07-30 2014-11-27 Sun Pharmaceutical Industries Limited Process for the preparation of carbapenem compounds
EP2334298B1 (en) * 2008-09-18 2014-07-30 Manu Chaudhary Novel single unit carbapenem aminoglycoside formulations
WO2010124531A1 (zh) 2009-04-30 2010-11-04 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南中间体、含其的组合物及其制备方法
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8729260B2 (en) 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
KR20150065176A (ko) * 2012-10-12 2015-06-12 산도즈 아게 에르타페넴 중간체의 제조법
JP2016517435A (ja) * 2013-03-15 2016-06-16 カラ ファーマシューティカルズ インコーポレイテッド メロペネム誘導体及びその使用
IN2013MU03862A (zh) 2013-12-11 2015-07-31 Unimark Remedies Ltd
WO2017158616A1 (en) 2016-03-16 2017-09-21 Orchid Pharma Ltd. Carbapenem compounds
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺
CN110698480B (zh) * 2018-07-09 2023-09-08 武汉启瑞药业有限公司 一种厄他培南中间体的合成及纯化方法
MX2021008937A (es) * 2019-01-23 2021-11-12 Glycolysis Biomed Co Ltd Compuestos de beta-lactama o sales de los mismos para su uso en la prevencion o tratamiento de accion prolongada del trastorno del metabolismo de la glucosa.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
US4974544A (en) * 1986-10-07 1990-12-04 Ricoh Company, Co. Vapor deposition apparatus
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
JP2559949B2 (ja) * 1991-06-04 1996-12-04 三共株式会社 １−メチルカルバペネム誘導体
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2106141A1 (en) * 1992-09-28 1994-03-29 Michael J. Betts Antibiotic compounds

Also Published As

Publication number Publication date
YU5493A (sh) 1996-05-20
GB9300456D0 (en) 1993-03-03
NO2002010I2 (no) 2005-03-11
US5478820A (en) 1995-12-26
CN1036006C (zh) 1997-10-01
CN1079224A (zh) 1993-12-08
AP9300480A0 (en) 1993-01-31
HU213675B (en) 1997-09-29
UA44885C2 (uk) 2002-03-15
NZ246917A (en) 1995-09-26
DE10299041I2 (de) 2003-06-12
CZ206793A3 (en) 1994-04-13
NL300104I1 (nl) 2002-12-02
CA2106370A1 (en) 1993-08-05
EP0579826B1 (en) 1998-11-11
NO933530D0 (no) 1993-10-01
AU3457493A (en) 1993-09-01
US6187804B1 (en) 2001-02-13
FI104074B1 (fi) 1999-11-15
CA2106370C (en) 2003-11-25
FI930474A (fi) 1993-08-05
AU668133B2 (en) 1996-04-26
AP398A (en) 1995-08-29
US20020042408A1 (en) 2002-04-11
US6521612B2 (en) 2003-02-18
PL174936B1 (pl) 1998-10-30
FI104074B (fi) 1999-11-15
RU2117659C1 (ru) 1998-08-20
HUT66514A (en) 1994-12-28
FI930474A0 (fi) 1993-02-03
EP0579826A1 (en) 1994-01-26
IL104588A (en) 1999-03-12
YU48998B (sh) 2003-04-30
DK0579826T3 (da) 1999-07-26
GB9202298D0 (en) 1992-03-18
HRP930103A2 (en) 1994-12-31
TW408124B (en) 2000-10-11
US20050209212A1 (en) 2005-09-22
SK280890B6 (sk) 2000-09-12
SG48817A1 (en) 1998-05-18
SK106393A3 (en) 1994-04-06
IL104588A0 (en) 1993-06-10
DE69322007D1 (de) 1998-12-17
HU211840A9 (en) 1995-12-28
PL174601B1 (pl) 1998-08-31
US7342005B2 (en) 2008-03-11
MY111685A (en) 2000-11-30
ES2123654T3 (es) 1999-01-16
US5652233A (en) 1997-07-29
LU90970I2 (fr) 2002-12-09
NZ272038A (en) 1997-07-27
CZ286878B6 (en) 2000-07-12
US20030144264A1 (en) 2003-07-31
HUT64764A (en) 1994-02-28
SI9300056B (sl) 2000-02-29
NO2002010I1 (no) 2002-10-09
NL300104I2 (nl) 2003-02-03
US5856321A (en) 1999-01-05
HK1013998A1 (en) 1999-09-17
DE69322007T2 (de) 1999-04-01
NO933530L (no) 1993-10-04
DE10299041I1 (de) 2003-02-20
JP2730600B2 (ja) 1998-03-25
WO1993015078A1 (en) 1993-08-05
NO304315B1 (no) 1998-11-30
PL174649B1 (pl) 1998-08-31
SI9300056A (en) 1993-09-30
HU9302777D0 (en) 1993-12-28
KR100200986B1 (ko) 1999-06-15
ATE173262T1 (de) 1998-11-15
HRP930103B1 (en) 1999-12-31
JPH06506704A (ja) 1994-07-28
US7041836B2 (en) 2006-05-09
GEP20022694B (en) 2002-05-10

Similar Documents

Publication Publication Date Title
GB9202298D0 (en) Antibiotic compounds
AP9300508A0 (en) Compounds
GB9200245D0 (en) Compounds
GB9201755D0 (en) Compounds
GB9200210D0 (en) Compounds
GB9201694D0 (en) Compounds
GB9201693D0 (en) Compounds
ZW3493A1 (en) Antibiotic compounds
GB9200209D0 (en) Compounds
GB9200566D0 (en) Compounds
GB9201751D0 (en) Compounds
GB9107342D0 (en) Antibiotic compounds
GB9202792D0 (en) Compounds
GB9201692D0 (en) Compounds
GB9206307D0 (en) Antibiotic compounds
GB9107343D0 (en) Antibiotic compounds
GB9107338D0 (en) Antibiotic compounds
GB9005469D0 (en) Antibiotic compounds
GB9005465D0 (en) Antibiotic compounds
GB9005470D0 (en) Antibiotic compounds
ZA931611B (en) Antibiotic compounds.
GB9201746D0 (en) Compounds
GB9201748D0 (en) Compounds
GB9200101D0 (en) Compounds
GB9203169D0 (en) Compounds